The mission of The Particle Technology and Crystallization Center (PTCC) is to foster a unique mechanism for addressing important problems in particle technology and crystallization in the pharmaceutical industry. The PTCC collaborative team consists of Illinois Institute of Technology, concentrating on particle technology and crystallization research and includes characterization facilities at the Advanced Photon Source (APS) at Argonne National Laboratory; the Department of Industrial and Physical Pharmacy at Purdue University, whose work targets polymorphism, materials science, spectroscopic analysis, and manufacturing; and Massachusetts Institute of Technology, which centers on the study of process analysis and benchmarking. The center is a not-for-profit organization administrated through IIT and its aim is to catalyze interaction between industrial and academic scientists and facilitate the application of novel technologies in pharmaceutical manufacturing processes.

In step with our times, PTCC aims to become a leading educational and research entity in Particle Technology and Crystallization of not only small molecules but macromolecules, of chemical and biological type. Cognizant of the numerous challenges the pharmaceutical industry faces in terms of regulatory compliance, PTCC will continue to pursue projects responding to FDA initiatives on Quality and Manufacturing Practices, QBD, 21st cGMP, e.g., development of sensors and analytical techniques for manufacturing processes.